Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion type Assertion NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_head.
- NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion wasGeneratedBy ECO_0000203 NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_provenance.
- NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion wasDerivedFrom befree-2016 NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_provenance.
- NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion SIO_000772 22351695 NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_provenance.
- NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion evidence source_evidence_literature NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_provenance.
- NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_assertion description "[ON 01910.Na (Rigosertib), a multikinase phosphoinositide 3-kinase (PI3K) inhibitor, is entering phase III trials for myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962281.RAJcTTJl5eRm1bjhuB-a22-npsSZ6-PDqhc6PDHhhbOM4130_provenance.